Anti-science case study: COVID-19 vaccines' effectiveness and safety exaggerated.
作者信息
Lataster Raphael
机构信息
University of Sydney, Sydney, Australia.
出版信息
Public Health Pract (Oxf). 2024 May 23;7:100517. doi: 10.1016/j.puhip.2024.100517. eCollection 2024 Jun.
Abstract
摘要
相似文献
1
Anti-science case study: COVID-19 vaccines' effectiveness and safety exaggerated.
Public Health Pract (Oxf). 2024 May 23;7:100517. doi: 10.1016/j.puhip.2024.100517. eCollection 2024 Jun.
2
[Application of epidemiology research in evaluations of COVID-19 vaccines in both clinical trial and clinical use].
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Jan 10;43(1):7-13. doi: 10.3760/cma.j.cn112338-20210902-00705.
3
Exploring future perspectives and pipeline progression in vaccine research and development.
Ann Ig. 2024 Jul-Aug;36(4):446-461. doi: 10.7416/ai.2024.2614. Epub 2024 Mar 1.
4
Who is "anti-science"?
Public Health Pract (Oxf). 2024 Mar 29;7:100493. doi: 10.1016/j.puhip.2024.100493. eCollection 2024 Jun.
5
Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.
Vaccine. 2023 Jun 13;41(26):3801-3812. doi: 10.1016/j.vaccine.2023.05.048. Epub 2023 May 22.
6
COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review.
Arch Acad Emerg Med. 2022 Jul 4;10(1):e53. doi: 10.22037/aaem.v10i1.1582. eCollection 2022.
7
Forty days of regulatory emergency use authorisation of COVID-19 vaccines: Interfacing efficacy, hesitancy and SDG target 3.8.
Glob Public Health. 2021 Oct;16(10):1537-1558. doi: 10.1080/17441692.2021.1938170. Epub 2021 Jun 9.
8
COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.
Vaccine. 2022 Oct 12;40(43):6271-6276. doi: 10.1016/j.vaccine.2022.08.070. Epub 2022 Sep 14.
9
Heterologous prime-boost strategies for COVID-19 vaccines.
J Travel Med. 2022 May 31;29(3). doi: 10.1093/jtm/taab191.
10
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case-control study.
BMJ Open. 2023 Jun 27;13(6):e071789. doi: 10.1136/bmjopen-2023-071789.
引用本文的文献
1
What Lessons can Be Learned From the Management of the COVID-19 Pandemic?
Int J Public Health. 2025 May 30;70:1607727. doi: 10.3389/ijph.2025.1607727. eCollection 2025.
2
Amid Growing Evidence of Conflicts of Interest and Obdurate Groupthink in Medical Journals, Researchers Must Entertain Contrarian Ideas.
Cureus. 2025 Jan 23;17(1):e77895. doi: 10.7759/cureus.77895. eCollection 2025 Jan.
本文引用的文献
1
Who is "anti-science"?
Public Health Pract (Oxf). 2024 Mar 29;7:100493. doi: 10.1016/j.puhip.2024.100493. eCollection 2024 Jun.
2
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
Vaccine. 2024 Apr 2;42(9):2357-2369. doi: 10.1016/j.vaccine.2024.03.001. Epub 2024 Mar 6.
3
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12.
4
How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID-19 vaccines.
J Eval Clin Pract. 2024 Apr;30(3):453-458. doi: 10.1111/jep.13962. Epub 2024 Jan 18.
5
How the case counting window affected vaccine efficacy calculations in randomized trials of COVID-19 vaccines.
J Eval Clin Pract. 2024 Feb;30(1):105-106. doi: 10.1111/jep.13900. Epub 2023 Jul 15.
6
Reply to Fung et al. on COVID-19 vaccine case-counting window biases overstating vaccine effectiveness.
J Eval Clin Pract. 2024 Feb;30(1):82-85. doi: 10.1111/jep.13892. Epub 2023 Jul 4.
7
Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects?
iScience. 2023 May 19;26(5):106733. doi: 10.1016/j.isci.2023.106733. Epub 2023 Apr 25.
8
Sources of bias in observational studies of covid-19 vaccine effectiveness.
J Eval Clin Pract. 2024 Feb;30(1):30-36. doi: 10.1111/jep.13839. Epub 2023 Mar 26.
9
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Vaccine. 2022 Sep 22;40(40):5798-5805. doi: 10.1016/j.vaccine.2022.08.036. Epub 2022 Aug 31.
10
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.
BMJ. 2021 Nov 2;375:n2635. doi: 10.1136/bmj.n2635.
Zotero 插件